Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Silvio Danese and Gionata Fiorino.
Silvio Danese
Connection Strength
13.312
Gionata Fiorino
  1. Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures. Am J Gastroenterol. 2020 10; 115(10):1719-1721.
    View in: PubMed
    Score: 0.906
  2. Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience. J Crohns Colitis. 2020 Sep 16; 14(9):1330-1333.
    View in: PubMed
    Score: 0.903
  3. Protecting patients with IBD during the COVID-19 pandemic. Lancet Gastroenterol Hepatol. 2020 07; 5(7):639.
    View in: PubMed
    Score: 0.883
  4. Clinician Education and Adoption of Preventive Measures for COVID-19: A Survey of a Convenience Sample of General Practitioners in Lombardy, Italy. Ann Intern Med. 2020 09 01; 173(5):405-407.
    View in: PubMed
    Score: 0.877
  5. Effectiveness of Infliximab Biosimilar in Crohn's Disease: A Dime, A Dozen. Gastroenterology. 2019 06; 156(8):2349-2351.
    View in: PubMed
    Score: 0.820
  6. Anti-TNF Biosimilars in Inflammatory Bowel Disease: Searching the Proper Patient's Profile. Curr Med Chem. 2019; 26(2):280-287.
    View in: PubMed
    Score: 0.802
  7. JAK inhibitors: Novel developments in management of ulcerative colitis. Best Pract Res Clin Gastroenterol. 2018 Feb - Apr; 32-33:89-93.
    View in: PubMed
    Score: 0.769
  8. Full Interchangeability in Regard to Immunogenicity Between the Infliximab Reference Biologic and Biosimilars CT-P13 and SB2 in Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018 02 15; 24(3):601-606.
    View in: PubMed
    Score: 0.755
  9. The safety of biological pharmacotherapy for the treatment of ulcerative colitis. Expert Opin Drug Saf. 2017 Apr; 16(4):437-443.
    View in: PubMed
    Score: 0.708
  10. Patients with Inflammatory Bowel Disease Are Not at Increased Risk of COVID-19: A Large Multinational Cohort Study. J Clin Med. 2020 Oct 31; 9(11).
    View in: PubMed
    Score: 0.228
  11. Clinical course of COVID-19 in 41 patients with immune-mediated inflammatory diseases: Experience from humanitas center, Milan. Pharmacol Res. 2020 10; 160:105061.
    View in: PubMed
    Score: 0.223
  12. Maintaining the Quality Standards of Care for Inflammatory Bowel Disease Patients During the COVID-19 Pandemic. Clin Gastroenterol Hepatol. 2020 07; 18(8):1882-1883.
    View in: PubMed
    Score: 0.219
  13. Psychological Characteristics of Inflammatory Bowel Disease Patients: A Comparison Between Active and Nonactive Patients. Inflamm Bowel Dis. 2019 07 17; 25(8):1399-1407.
    View in: PubMed
    Score: 0.208
  14. Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience. Therap Adv Gastroenterol. 2019; 12:1756284819848631.
    View in: PubMed
    Score: 0.206
  15. Noninvasive Multimodal Methods to Differentiate Inflamed vs Fibrotic Strictures in Patients With Crohn's Disease. Clin Gastroenterol Hepatol. 2019 11; 17(12):2397-2415.
    View in: PubMed
    Score: 0.205
  16. Illness Perception in Inflammatory Bowel Disease Patients is Different Between Patients With Active Disease or in Remission: A Prospective Cohort Study. J Crohns Colitis. 2019 Mar 30; 13(4):417-423.
    View in: PubMed
    Score: 0.204
  17. Vedolizumab for the treatment of inflammatory bowel diseases: from symptomatic control to mucosal healing. Immunotherapy. 2019 05; 11(7):565-575.
    View in: PubMed
    Score: 0.203
  18. Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study. J Crohns Colitis. 2018 Nov 28; 12(12):1385-1391.
    View in: PubMed
    Score: 0.199
  19. Comparative Accuracy of Bowel Ultrasound Versus Magnetic Resonance Enterography in Combination With Colonoscopy in Assessing Crohn's Disease and Guiding Clinical Decision-making. J Crohns Colitis. 2018 Nov 15; 12(11):1280-1287.
    View in: PubMed
    Score: 0.199
  20. The role of multimodal treatment in Crohn's disease patients with perianal fistula: a multicentre retrospective cohort study. Aliment Pharmacol Ther. 2018 11; 48(9):941-950.
    View in: PubMed
    Score: 0.197
  21. PF-00547659 for the treatment of Crohn's disease and ulcerative colitis. Expert Opin Investig Drugs. 2018 Jul; 27(7):623-629.
    View in: PubMed
    Score: 0.194
  22. Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials. Expert Opin Investig Drugs. 2018 07; 27(7):595-599.
    View in: PubMed
    Score: 0.194
  23. Can IL-23 be a good target for ulcerative colitis? Best Pract Res Clin Gastroenterol. 2018 Feb - Apr; 32-33:95-102.
    View in: PubMed
    Score: 0.192
  24. Identification of Endpoints for Development of Antifibrosis Drugs for Treatment of Crohn's Disease. Gastroenterology. 2018 07; 155(1):76-87.
    View in: PubMed
    Score: 0.190
  25. Sexual and reproductive issues and inflammatory bowel disease: a neglected topic in men. Eur J Gastroenterol Hepatol. 2018 Mar; 30(3):316-322.
    View in: PubMed
    Score: 0.189
  26. Vedolizumab for the treatment of Crohn's disease. Expert Rev Clin Immunol. 2018 03; 14(3):179-189.
    View in: PubMed
    Score: 0.189
  27. Comparison of two methods for the in-vivo diagnosis of Helicobacter pylori infection using a tablet of 13C-urea. Minerva Gastroenterol Dietol. 2017 Dec; 63(4):319-326.
    View in: PubMed
    Score: 0.186
  28. Biosimilar Drugs for Inflammatory Bowel Disease: Is Similar Good Enough? Dig Dis Sci. 2017 11; 62(11):2964-2965.
    View in: PubMed
    Score: 0.185
  29. Effectiveness of Mesalazine, Thiopurines and Tumour Necrosis Factor Antagonists in Preventing Post-Operative Crohn's Disease Recurrence in a Real-Life Setting. Digestion. 2017; 96(3):166-172.
    View in: PubMed
    Score: 0.183
  30. Early intervention in Crohn's disease: towards disease modification trials. Gut. 2017 12; 66(12):2179-2187.
    View in: PubMed
    Score: 0.183
  31. MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in Mice. Gastroenterology. 2017 11; 153(5):1363-1377.e6.
    View in: PubMed
    Score: 0.182
  32. Novel therapeutic targets for inflammatory bowel disease. J Autoimmun. 2017 Dec; 85:103-116.
    View in: PubMed
    Score: 0.181
  33. Filgotinib in Crohn's Disease: JAK Is Back. Gastroenterology. 2017 Aug; 153(2):603-605.
    View in: PubMed
    Score: 0.180
  34. Efficacy of tumour necrosis factor antagonists in stricturing Crohn's disease: A tertiary center real-life experience. Dig Liver Dis. 2017 Aug; 49(8):872-877.
    View in: PubMed
    Score: 0.178
  35. The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar. Inflamm Bowel Dis. 2017 02; 23(2):233-243.
    View in: PubMed
    Score: 0.176
  36. IL-23 Blockade for Crohn s disease: next generation of anti-cytokine therapy. Expert Rev Clin Immunol. 2017 05; 13(5):457-467.
    View in: PubMed
    Score: 0.175
  37. The Experience with Biosimilars of Infliximab in Inflammatory Bowel Disease. Curr Pharm Des. 2017; 23(44):6759-6769.
    View in: PubMed
    Score: 0.175
  38. Viewpoint: knowledge and viewpoints on biosimilar monoclonal antibodies among members of the European Crohn's and Colitis Organization. J Crohns Colitis. 2014 Nov; 8(11):1548-50.
    View in: PubMed
    Score: 0.147
  39. SFED recommendations for IBD endoscopy during COVID-19 pandemic: Italian and French experience. Nat Rev Gastroenterol Hepatol. 2020 08; 17(8):507-516.
    View in: PubMed
    Score: 0.055
  40. Outcomes of COVID-19 in 79 patients with IBD in Italy: an IG-IBD study. Gut. 2020 07; 69(7):1213-1217.
    View in: PubMed
    Score: 0.055
  41. Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts. Clin Gastroenterol Hepatol. 2020 08; 18(9):2134-2135.
    View in: PubMed
    Score: 0.055
  42. Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study. Eur J Gastroenterol Hepatol. 2019 Nov; 31(11):1361-1369.
    View in: PubMed
    Score: 0.053
  43. Corrigendum: Perception of Reproductive Health in Women with Inflammatory Bowel Disease. J Crohns Colitis. 2019 05 27; 13(6):815.
    View in: PubMed
    Score: 0.052
  44. Are Surgical Rates Decreasing in the Biological Era In IBD? Curr Drug Targets. 2019; 20(13):1356-1362.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.